Biobanking Consumables Sales

Biobanking Consumables Sales Market Outlook

The global biobanking consumables market is anticipated to reach approximately USD 2 billion by 2035, expanding at a remarkable compound annual growth rate (CAGR) of 8.2% from 2025 to 2035. The growth factors driving this market include the increasing focus on personalized medicine, advancements in biobanking technologies, and the rising prevalence of chronic diseases necessitating extensive research and development. The demand for biobanking consumables is further amplified by the growing investments in research and development activities across the life sciences sector. Additionally, the increasing number of biobanks being established worldwide, coupled with collaborations between various research institutions, is propelling the market forward. Furthermore, the rising global population and consequent health issues are also leading to an increased need for biobanking consumables, thus fostering market growth.

Growth Factor of the Market

Several factors contribute significantly to the growth of the biobanking consumables market. One of the most prominent growth factors is the rising trend of personalized medicine, where biobanks play a pivotal role in providing the necessary biological samples for research and clinical trials. Moreover, technological advancements in biobanking such as automated sample handling and cryopreservation techniques enhance the efficiency and reliability of biobanks, making them indispensable in contemporary medical research. The increasing prevalence of genetic disorders and the chronic disease burden further necessitate the establishment of more biobanks and the procurement of consumables to support ongoing research. Furthermore, collaborations between biobanks and pharmaceutical companies have surged, enhancing the relevance of biobanking in drug development processes. The supportive regulatory environment and government initiatives promoting research in biobanking also add momentum to the market's growth.

Key Highlights of the Market

• The global biobanking consumables market is projected to grow at a CAGR of 8.2% from 2025 to 2035.
• There is a notable increase in partnerships between biobanks and pharmaceutical companies to facilitate drug development.
• Technological advancements in biobanking processes are enhancing efficiency and reliability.
• The rising prevalence of chronic diseases is driving the demand for biobanking consumables.
• Government initiatives and regulatory support are fostering the establishment of more biobanks globally.

By Product Type

Sample Tubes:

Sample tubes are one of the most vital consumables used in biobanking, as they are crucial for the collection and storage of biological samples. These tubes come in various sizes and are designed to handle different types of samples, including blood, saliva, and other bodily fluids. The growing focus on precision medicine is significantly driving the demand for sample tubes, as they are essential for preserving the integrity of samples during the biobanking process. The introduction of innovative materials, such as enhanced barrier technology, has significantly improved the performance of sample tubes, making them more reliable for long-term storage. Additionally, the rise in clinical trials and research activities necessitates the need for high-quality sample tubes, further boosting the market segment. Furthermore, manufacturers are focusing on developing user-friendly designs for sample tubes, ensuring ease of use for healthcare professionals and researchers alike.

Sample Boxes:

Sample boxes are integral to the biobanking process, specifically designed to securely store and transport biological samples. These boxes are manufactured with specific materials to provide optimal protection against environmental factors, ensuring that samples remain stable during transit and storage. The increasing establishment of biobanks around the world has led to a surge in demand for sample boxes, as they are essential for maintaining sample integrity. Innovations in design and materials have also enhanced the functionality of sample boxes, allowing for better organization and labeling of samples. The growing trend of biobanks collaborating with research institutions and healthcare facilities is further driving the need for efficient sample storage solutions, making sample boxes an essential component of the biobanking consumables market. With the focus on improving logistics and handling during sample transportation, the development of eco-friendly sample boxes has also gained traction within the industry.

Cryogenic Vials:

Cryogenic vials are pivotal in the biobanking sector as they are specifically designed to store biological samples at ultra-low temperatures. These vials are essential for preserving the viability of cells, tissues, and other biological materials, allowing for long-term storage without degradation. The increasing adoption of cryogenic storage methods among biobanks is a significant driver for this market segment. With advancements in cryogenic storage technology, manufacturers are designing vials that offer better insulation and lower rates of evaporation, enhancing the overall effectiveness of the storage process. As regenerative medicine and stem cell research continue to expand, the demand for cryogenic vials is expected to rise. Furthermore, regulatory requirements for sample preservation are increasing, making high-quality cryogenic vials a necessity for biobanks globally. This segment is also seeing the introduction of various sizes and formats of cryogenic vials to cater to diverse sample storage needs.

Cryogenic Bags:

Cryogenic bags are gaining traction in the biobanking consumables market as they offer an efficient solution for storing larger volumes of biological samples at ultra-low temperatures. These bags are designed to be flexible and durable, allowing for the safe containment of samples while preventing contamination. The rising demand for biobanking in regenerative medicine and tissue engineering is propelling the need for cryogenic bags, enabling the storage of complex biological materials such as organs and tissues. Additionally, the development of advanced materials for cryogenic bags has improved their performance, providing better security against leakage and puncture. As biobanking practices evolve, the versatility of cryogenic bags is becoming increasingly recognized, allowing for easier handling and transportation of biological samples. Moreover, the emphasis on cost-effective storage solutions is further driving the adoption of cryogenic bags in biobanking facilities.

Others:

The 'Others' category encompasses a variety of biobanking consumables that are essential for various applications within the biobank environment. This includes items such as storage racks, labeling systems, and sample preparation kits that facilitate the overall biobanking process. The growing complexity of biobanks and the diverse range of biological materials being stored have led to an increased demand for these ancillary products. Innovations in design and functionality, such as modular storage solutions and automated labeling systems, are enhancing the operational efficiency of biobanks. As research in biotechnology and life sciences expands, the need for comprehensive consumable solutions is becoming increasingly important, driving the growth of this segment. Moreover, with a greater emphasis on quality control and standardization in biobanking practices, the demand for specialized consumables is expected to grow significantly in the coming years.

By Application

Clinical Biobanking:

Clinical biobanking is a crucial aspect of modern medicine, focusing on the storage of biological samples collected from patients for research and diagnostic purposes. This application segment is witnessing significant growth due to the increasing number of clinical trials aimed at developing personalized treatments. Biobanks play an essential role in providing researchers with the necessary samples to study the genetic basis of diseases, evaluate treatment responses, and develop novel therapeutics. The establishment of large-scale clinical biobanks has emerged as a vital resource for improving patient outcomes and advancing medical research. As healthcare systems worldwide continue to emphasize evidence-based medicine, the demand for clinical biobanking solutions is poised for substantial growth, thereby boosting the consumables market associated with this segment.

Regenerative Medicine:

Regenerative medicine is a rapidly evolving field that aims to repair or replace damaged tissues and organs by utilizing biological samples sourced from biobanks. The increasing focus on regenerative therapies is significantly driving the demand for biobanking consumables, as high-quality samples are essential for the development and testing of these innovative treatments. Biobanks serve as repositories for stem cells, tissues, and other regenerative materials, facilitating research in this promising area of medicine. Moreover, advancements in stem cell research and tissue engineering are creating new opportunities for biobanks to support cutting-edge regenerative therapies. The growing investments in regenerative medicine research and the rising prevalence of chronic diseases are further bolstering the need for consumables that ensure the integrity and viability of biological samples for therapeutic applications.

Life Science Research:

Life science research encompasses a broad range of scientific disciplines, including molecular biology, genetics, and pharmacology, all of which rely on biobanks for sourcing valuable biological samples. The demand for biobanking consumables in this segment is driven by the increasing number of research initiatives aimed at understanding complex biological processes and developing new treatment modalities. Biobanks provide essential materials for researchers to conduct experiments and clinical studies, thereby accelerating discoveries in life sciences. With the rise of personalized medicine and genomics, the demand for high-quality biological samples is more critical than ever, propelling the growth of consumables tailored for life science research purposes. Additionally, the collaboration between academic institutions and biobanks is fostering a conducive environment for research, further increasing the market potential for biobanking consumables in life science applications.

Others:

The 'Others' category within applications includes various specialized fields that utilize biobanking samples, such as veterinary medicine, forensic analysis, and environmental studies. These diverse applications are emerging as significant contributors to the overall demand for biobanking consumables. As researchers explore innovative ways to utilize biological samples in these fields, the need for specific consumables is growing. This segment's growth is bolstered by advancements in technology that allow for more sophisticated analyses of samples, whether for improving animal health, solving forensic cases, or studying ecological impacts. Furthermore, the increasing recognition of biobanking's potential in non-traditional fields is expected to stimulate further development and investment in consumables tailored for these unique applications.

By Distribution Channel

Direct Sales:

Direct sales represent a significant channel for biobanking consumables, offering manufacturers the opportunity to engage directly with their customers, which often include hospitals, research institutions, and biobanks themselves. This distribution model allows for greater control over pricing strategies, product availability, and customer relationships. As the biobanking industry continues to expand, more manufacturers are adopting direct sales strategies to meet the specific needs of clients and ensure timely delivery of consumables. The direct sales approach also facilitates better communication and feedback, enabling manufacturers to innovate and refine their offerings based on customer insights. Furthermore, direct sales often provide educational resources and support, helping clients understand the importance of selecting high-quality consumables for their biobanking operations.

Distributor Sales:

Distributor sales play a crucial role in the biobanking consumables market by serving as intermediaries between manufacturers and end-users. Distributors often have established networks and relationships that allow them to reach a broader audience, including small and medium-sized biobanks that may not have direct access to manufacturers. This model is particularly beneficial for manufacturers looking to expand their market reach without incurring the costs associated with direct sales. Distributors typically offer a comprehensive portfolio of consumables, providing customers with various options to choose from, which can be advantageous for biobanks with diverse needs. Furthermore, distributors often provide value-added services such as inventory management, technical support, and training to ensure customers are satisfied with their purchases and the products meet their operational requirements.

By Material Type

Plastic:

Plastic is the most widely used material in the production of biobanking consumables, owing to its versatility, lightweight nature, and cost-effectiveness. Various types of plastic, such as polypropylene and polyethylene, are employed to manufacture items like sample tubes, containers, and cryogenic vials. The ability of plastic to be molded into various shapes and sizes allows for the creation of customized solutions tailored to specific biobanking needs. Additionally, advancements in plastic technology have led to the development of high-quality, durable products that can withstand the rigors of storage and transportation. The growing emphasis on safety and sterility in biobanking further drives the demand for plastic consumables, as many plastic products can be manufactured as single-use items, reducing the risk of contamination. As the market continues to evolve, innovations in biocompatible and biodegradable plastics are expected to enhance the sustainability of biobanking practices.

Glass:

Glass is another material frequently utilized in biobanking consumables, particularly for items that require a higher degree of chemical resistance and sample integrity. Glass vials, containers, and tubes are often preferred for storing sensitive biological samples, as they do not leach chemicals and provide an inert environment. The superior clarity of glass also allows for easy visibility of contents, which is particularly advantageous in laboratory settings. The rising focus on maintaining sample quality and integrity drives the demand for glass biobanking consumables, especially among high-end research institutions and biobanks aiming to ensure the highest standards in sample preservation. Additionally, glass products can be sterilized and reused, contributing to more sustainable biobanking practices. However, the weight and fragility of glass compared to plastic can pose challenges in certain applications, leading to a balanced preference for both materials in the market.

Silicone:

Silicone is increasingly being recognized as a valuable material in the biobanking consumables sector, particularly for applications requiring flexibility and durability. Silicone offers excellent temperature resistance, making it suitable for various biobanking processes, including cryogenic storage. The biocompatibility of silicone also makes it a preferred choice for certain biological samples, ensuring that sample integrity is preserved without contamination. The growth of biobanking applications in regenerative medicine and tissue engineering has driven the demand for silicone-based consumables, as these products can be engineered to meet specific requirements. Innovations in silicone technology are leading to the development of customized solutions, such as silicone mats and seals, which improve the usability and functionality of biobanking systems. As the focus on quality and reliability in biobanking increases, silicone is expected to gain further traction in this market segment.

Others:

The 'Others' category of material types encompasses a variety of alternative materials used in biobanking consumables, such as stainless steel and composite materials. These materials are often utilized for specific applications requiring unique properties, such as enhanced strength, temperature resistance, or specialized functionality. For instance, stainless steel is commonly used in laboratory equipment and storage systems due to its durability and ease of sterilization. Additionally, composite materials may offer a combination of benefits from different substrates, providing tailored solutions for specific biobanking challenges. As biobanking evolves and expands into new applications, the demand for innovative materials will continue to grow, encouraging manufacturers to explore diverse options and expand their product lines accordingly.

By Region

North America dominates the global biobanking consumables market, accounting for approximately 40% of the total market share in 2025. This region's leadership can be attributed to the presence of advanced healthcare infrastructure, significant investments in medical research, and a growing number of biobanks established for clinical and research purposes. The increasing prevalence of chronic diseases and genetic disorders in North America is further propelling the demand for biobanking solutions, driving the market's growth. The CAGR for the North American biobanking consumables market is projected to be around 8.5% during the forecast period, highlighting the continued investments made in healthcare and research initiatives. Furthermore, collaborations between academic institutions, biotechnology firms, and public health organizations are shaping the biobanking landscape, enhancing the need for consumables.

Europe is the second-largest market for biobanking consumables, accounting for approximately 30% of the global share in 2025. The region's focus on advancing healthcare research and the establishment of biobanks for personalized medicine initiatives are key factors driving market growth in Europe. The European Union's investments in healthcare programs and the increasing demand for biobanking solutions for clinical trials contribute to the region's robust market outlook. Additionally, the growing emphasis on ethical biobanking practices and sample sharing across borders is fostering collaborative research, further enhancing the demand for biobanking consumables. The CAGR for the European biobanking consumables market is anticipated to be around 7.8% during the forecast period, reflecting the ongoing advancements in research and development activities.

Opportunities

The biobanking consumables market presents numerous opportunities for growth, especially as the demand for personalized medicine and advanced therapies continues to rise. With the increasing prevalence of chronic diseases and genetic disorders worldwide, the need for high-quality biological samples is becoming more pressing. Biobanks serve as essential repositories for these samples, and as more organizations recognize the value of biobanking, there will be a corresponding increase in the establishment of new biobanks. This trend creates a significant opportunity for consumables manufacturers to expand their product offerings and cater to the specific needs of these new facilities. Additionally, advancements in technology, such as automation and sample tracking systems, are evolving the biobanking landscape, creating demand for specialized consumables that can enhance operational efficiency.

Moreover, the globalization of research initiatives is paving the way for collaborative biobanking efforts across borders, presenting an excellent opportunity for consumables manufacturers to tap into international markets. By partnering with biobanks and research institutions worldwide, manufacturers can expand their reach and foster innovative solutions tailored to diverse research requirements. The rising focus on sustainable practices in biobanking also opens doors for manufacturers to develop eco-friendly consumables and solutions that align with the growing emphasis on environmental responsibility. Overall, the evolving landscape of biobanking offers numerous opportunities for growth, innovation, and the introduction of advanced consumable solutions.

Threats

Despite the promising outlook of the biobanking consumables market, several threats could impede its growth. One of the primary concerns is the increasing competition among consumables manufacturers, which may lead to price wars and a subsequent decline in profit margins. As the market expands and more players enter the field, maintaining a competitive edge becomes challenging. Furthermore, the stringent regulatory environment governing biobanking practices poses additional challenges, as compliance with regulations can lead to increased production costs and delays in product launches. Manufacturers must ensure that their consumables meet the required quality and safety standards, which can be a daunting task, especially for smaller companies without extensive resources.

Additionally, the ongoing challenges related to the global supply chain can also impact the availability and pricing of biobanking consumables. Disruptions caused by geopolitical tensions, natural disasters, or pandemics can lead to delays in raw material supply, affecting manufacturers' ability to meet market demand. Moreover, the potential for negative public perception regarding biobanking practices, such as ethical concerns surrounding sample collection and usage, may hinder the growth of the market. Addressing these threats requires manufacturers to adopt adaptive strategies, invest in quality assurance, and continuously engage with stakeholders to build trust and confidence in their products.

Competitor Outlook

• Thermo Fisher Scientific
• Corning Inc.
• VWR International LLC
• Sartorius AG
• Greiner Bio-One International GmbH
• Merck KGaA
• Bio-Rad Laboratories, Inc.
• Lonza Group AG
• Fisher Scientific
• Starlab International GmbH
• Celltreat Scientific Products
• Hettich Lab Technology
• Brand GmbH + Co KG
• Roche Diagnostics
• BD Biosciences

The competitive landscape of the biobanking consumables market is characterized by the presence of several established players as well as smaller companies that specialize in niche offerings. Major companies such as Thermo Fisher Scientific and Corning Inc. hold significant market shares due to their comprehensive product portfolios and strong brand recognition. These companies have invested heavily in research and development to introduce innovative consumables that cater to the evolving demands of biobanks and research institutions. Their extensive distribution networks also enable them to reach a wide customer base, solidifying their position in the market.

In addition to the large players, various smaller companies are emerging, offering specialized products and solutions tailored to specific biobanking needs. These companies often focus on quality and innovation, allowing them to carve out a niche in the competitive landscape. Moreover, collaborations with research institutions and biobanks are becoming increasingly common, fostering partnerships that enhance the visibility and acceptance of their products in the market. As the demand for biobanking consumables continues to grow, the competitive dynamics may shift, leading to further consolidation in the industry as larger companies acquire smaller firms to expand their product offerings and market reach.

Key players such as Sartorius AG and Merck KGaA are also making notable strides in the biobanking consumables market. Sartorius AG has been recognized for its focus on bioprocessing and laboratory solutions, providing a range of consumables tailored to biobanking applications. Their commitment to research and development enables them to stay at the forefront of technological advancements in the sector. Similarly, Merck KGaA has positioned itself as a leader in the life sciences sector, offering innovative consumable solutions that address various biobanking needs. These companies are continuously working to enhance their product lines and develop next-generation consumables that meet the increasing demands of biobanks and research institutions globally.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Merck KGaA
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Corning Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Sartorius AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 BD Biosciences
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Lonza Group AG
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Fisher Scientific
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Roche Diagnostics
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Brand GmbH + Co KG
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 VWR International LLC
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Hettich Lab Technology
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Thermo Fisher Scientific
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Bio-Rad Laboratories, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Starlab International GmbH
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Celltreat Scientific Products
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Greiner Bio-One International GmbH
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Biobanking Consumables Sales Market, By Application
    • 6.1.1 Clinical Biobanking
    • 6.1.2 Regenerative Medicine
    • 6.1.3 Life Science Research
    • 6.1.4 Others
  • 6.2 Biobanking Consumables Sales Market, By Product Type
    • 6.2.1 Sample Tubes
    • 6.2.2 Sample Boxes
    • 6.2.3 Cryogenic Vials
    • 6.2.4 Cryogenic Bags
    • 6.2.5 Others
  • 6.3 Biobanking Consumables Sales Market, By Material Type
    • 6.3.1 Plastic
    • 6.3.2 Glass
    • 6.3.3 Silicone
    • 6.3.4 Others
  • 6.4 Biobanking Consumables Sales Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Distributor Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Biobanking Consumables Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Biobanking Consumables Sales market is categorized based on

By Product Type

• Sample Tubes
• Sample Boxes
• Cryogenic Vials
• Cryogenic Bags
• Others

By Application

• Clinical Biobanking
• Regenerative Medicine
• Life Science Research
• Others

By Distribution Channel

• Direct Sales
• Distributor Sales

By Material Type

• Plastic
• Glass
• Silicone
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific
• Corning Inc.
• VWR International LLC
• Sartorius AG
• Greiner Bio-One International GmbH
• Merck KGaA
• Bio-Rad Laboratories, Inc.
• Lonza Group AG
• Fisher Scientific
• Starlab International GmbH
• Celltreat Scientific Products
• Hettich Lab Technology
• Brand GmbH + Co KG
• Roche Diagnostics
• BD Biosciences